<DOC>
	<DOCNO>NCT01162005</DOCNO>
	<brief_summary>To determine efficacy tacrolimus management NS ( nephrotic syndrome ) , investigator design prospective study . The investigator enroll 100 child NS ( frequent relapse steroid dependent NS , steroid resistance NS ) treat tacrolimus ( 0.1-0.2 mg/kg/day two divide dos 12 h adjust trough level 5 10 ng/ml ) 12 month combination low-dose steroid . Other therapy include angiotensin-converting enzyme inhibitor , antihypertensive drug , multivitamins lipid-lowering agent . Follow-up every second week first 4 week , monthly . After initiation tacrolimus therapy , blood drawn visit determine tacrolimus trough level .</brief_summary>
	<brief_title>Therapeutic Effect Tacrolimus Primary Nephrotic Syndrome Children</brief_title>
	<detailed_description>Subsequently , monthly measurement make stable level tacrolimus achieve . Urine analyze proteinuria visit . Serum creatinine , glucose , albumin alanine aminotransferase measure complete blood count obtain visit study .</detailed_description>
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Nephrotic Syndrome</mesh_term>
	<mesh_term>Nephrosis</mesh_term>
	<mesh_term>Tacrolimus</mesh_term>
	<criteria>Frequent relapse nephrotic syndrome steroid resistance nephrotic syndrome secondary nephrotic syndrome estimate GFR &lt; 60 mL/min/1.73m2 active hepatitis</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>18 Years</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>Primary Nephrotic syndrome</keyword>
</DOC>